The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
QUINTESSENTIAL-2: A phase 3 study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide.
 
Eyal Lebel
No Relationships to Disclose
 
Ahmed Abdulgawad
Honoraria - Janssen; Kite, a Gilead Company
 
Stefania Bramanti
Honoraria - BeOne Medicines; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - BeOne Medicines; Bristol-Myers Squibb; Johnson & Johnson
Research Funding - BeOne Medicines; Bristol-Myers Squibb; Johnson & Johnson
 
P. Joy Ho
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Johnson & Johnson/Janssen; Pfizer
Research Funding - Novartis
Travel, Accommodations, Expenses - Gilead Sciences; Johnson & Johnson/Janssen
 
Mikko Keränen
No Relationships to Disclose
 
Yaël Cohen
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Johnson & Johnson; Karyopharm Therapeutics; Medison; Medison Neopharm; Roche; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Johnson & Johnson; Karyopharm Therapeutics; Medison; Medison Neopharm; Roche; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Johnson & Johnson; Karyopharm Therapeutics; Medison; Medison Neopharm; Roche; Takeda
 
Maja Vase
No Relationships to Disclose
 
Amit Khot
Honoraria - GlaxoSmithKline; Janssen
Consulting or Advisory Role - GlaxoSmithKline; Janssen
 
Ida Bruun Kristensen
Honoraria - Abbvie; Amgen; BeiGene; Johnson & Johnson; Menarini; Sanofi; Stemline Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Johnson & Johnson; Menarini; Sanofi; Stemline Therapeutics
Research Funding - Abbvie; Amgen; BeiGene; Johnson & Johnson; Menarini; Sanofi; Stemline Therapeutics
 
Cindy Lee
Honoraria - Antengene; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Pfizer
Consulting or Advisory Role - Antengene; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Pfizer
Research Funding - Antengene; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Johnson & Johnson; Pfizer
 
María-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Danielle Oh
Honoraria - AstraZeneca; Gilead Aus; Ricordati Aus
 
Katja Weisel
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Novartis; Oncopeptides; Pfizer; Regeneron; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; CellCentric; GlaxoSmithKline; Janssen-Cilag; Oncopeptides; Pfizer; Regeneron; Roche; Sanofi; Stemline Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen (Inst); Sanofi (Inst)
 
Sarah Larson
Stock and Other Ownership Interests - Janssen; Pfizer; Torl Biotherapeutics
Research Funding - Janssen; Pfizer; Torl Biotherapeutics
 
Kimberly Grazioli
Employment - Bristol-Myers Squibb
 
Ya Meng
Employment - Bristol-Myers Squibb
 
Lamis Eldjerou
Employment - Bristol-Myers Squibb
 
Susan Bal
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; AstraZeneca; Bristol Myers Squibb Foundation; Janssen Oncology; Kite/Arcellx; Pfizer
Research Funding - Amyloid Foundation (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); Fate Therapeutics (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Rakesh Popat
Honoraria - Abbvie; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Pfizer; Roche; Sanofi
Research Funding - Abbvie; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Pfizer; Roche; Sanofi
 
Paula Rodríguez-Otero
Consulting or Advisory Role - Abbvie; AstraZeneca; BMS; GlaxoSmithKline; H3 Biomedicine; Johnson and Johnson; Menarini Steamline; Oncopeptides; Pfizer; Roche; Sanofi
Speakers' Bureau - Abbvie; BMS; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Johnson and Johnson; Menarini Steamline; Sanofi
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer